Page 734 - Basic _ Clinical Pharmacology ( PDFDrive )
P. 734

40                           The Gonadal Hormones
                                A
                                   P
                         C
                            H
                                             R
                                          E
                                       T


                                                     & Inhibitors




                                                     George P. Chrousos, MD











                   C ASE  STUD Y

                   A 25-year-old woman with menarche at 13 years and   with premature ovarian failure, and estrogen and pro-
                   menstrual periods until about 1 year ago complains of hot   gesterone replacement therapy is recommended. A dual-
                   flushes, skin and vaginal dryness, weakness, poor sleep, and   energy absorptiometry scan (DEXA) reveals a bone density
                   scanty and infrequent menstrual periods of a year’s dura-  t-score of <2.5 SD, ie, frank osteoporosis. How should the
                   tion. She visits her gynecologist, who obtains plasma levels   ovarian hormones she lacks be replaced? What extra mea-
                   of follicle-stimulating hormone and luteinizing hormone,   sures should she take for her osteoporosis while receiving
                   both of which are moderately elevated. She is diagnosed   treatment?





                 ■   THE OVARY (ESTROGENS,                           hormone (GnRH). Despite extensive research in the field, the
                 PROGESTINS, OTHER                                   mechanism of puberty initiation still remains an enigma. Pulsatile
                                                                     pituitary gonadotropin secretion under the guidance of GnRH
                 OVARIAN HORMONES, ORAL                              definitely constitutes a sine qua non for pubertal onset. However,
                 CONTRACEPTIVES, INHIBITORS                          the secretion of GnRH in the human hypothalamus is regulated
                                                                     by kisspeptin and its receptor, as well as by permissive or opposing
                 & ANTAGONISTS, & OVULATION-                         signals mediated by neurokinin B and dynorphin acting on their
                 INDUCING AGENTS)                                    respective receptors.  These three supra-GnRH regulators com-
                                                                     pose the  Kisspeptin,  Neurokinin  B,  and  Dynorphin  neuron
                 The ovary has important gametogenic functions that are inte-  (KNDy) system, a key player in pubertal onset and progression.
                 grated  with  its  hormonal  activity.  In  the  human  female,  the   Recently, makorin ring finger protein 3 (MKRN3) was also
                 gonad is relatively quiescent during childhood, the period of   implicated in pubertal onset by contributing to the regulation
                 rapid  growth  and  maturation.  At  puberty,  the  ovary  begins  a   of  the  KNDy  system.  However,  the  inhibitory  (gamma-amino
                 30- to 40-year period of cyclic function called the  menstrual   butyric acid, neuropeptide  Y, and RFamide-related peptide-3)
                 cycle because of the regular episodes of bleeding that are its most   and stimulatory (glutamate) signals acting upstream of KNDy call
                 obvious manifestation. It then fails to respond to gonadotropins   into question the primary role of MKRN3 as the gatekeeper of
                 secreted by the anterior pituitary gland, and the cessation of cyclic   puberty. Recently, epigenetic mechanisms involving derepression
                 bleeding that occurs is called menopause.           of genes, such as that of kisspeptin, have been implicated in puber-
                   The mechanism responsible for the onset of ovarian func-  tal onset. Ultimately, withdrawal of a childhood-related inhibitory
                 tion  at  the  time  of  puberty  is  thought  to  be  neural  in  origin,   effect  upon  hypothalamic  arcuate  nucleus  neurons  allows  these
                 because the immature gonad can be stimulated by gonadotro-  neurons to produce GnRH in pulses with the appropriate ampli-
                 pins already present in the pituitary and because the pituitary is   tude, which stimulate the release of follicle-stimulating hormone
                 responsive to exogenous hypothalamic gonadotropin-releasing   (FSH) and luteinizing hormone (LH) (see Chapter 37). At first,

                 720
   729   730   731   732   733   734   735   736   737   738   739